SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Qubetics Network is a revolutionary blockchain ecosystem, designed to unify multiple networks and reshape the landscape of decentralized technology. As the world’s first Layer-1, EVM-compatible, aggregated multichain blockchain, Qubetics aims to enhance scalability, security, and interoperability. By bridging major blockchain platforms such as Ethereum, Solana, Cosmos, Bitcoin and more, it enables seamless cross-chain interactions, setting a new standard for decentralized applications (dApps), digital payments, and asset tokenization.

Qubetics

Qubetics ($TICS) is trending due to its focus on AI integration and interoperability within its Layer-1 blockchain, despite some initial challenges with its airdrop. The community is actively discussing its potential, partnerships, and the recent integration of WireGuard for enhanced privacy, while weighing the risks associated with the project's early stage and transparency concerns. Some users are claiming to have received their airdropped tokens, assuaging fears about a scam.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending as the crypto community discusses its recent price surge and potential for further growth, with some drawing comparisons to Bitcoin's early days. Community members are highlighting ZEC's privacy features and limited supply, suggesting it could be a valuable asset. The conversation also includes speculation about the potential impact of Grayscale's Zcash trust.

Hyperliquid is a performant L1 optimized from the ground up. The vision is a fully onchain open financial system with user built applications interfacing with performant native components, all without compromising end user experience. The Hyperliquid L1 is performant enough to operate an entire ecosystem of permissionless financial applications – every order, cancel, trade, and liquidation happens transparently on-chain with block latency <1 second. The chain currently supports 100k orders / second. The Hyperliquid L1 uses a custom consensus algorithm called HyperBFT which is heavily inspired by Hotstuff and its successors. Both the algorithm and networking stack are optimized from the ground up to support the L1. The flagship native application is a fully onchain order book perpetuals exchange, the Hyperliquid DEX. Further developments include a native token standard, spot trading, permissionless liquidity, etc.

Hype

Hype is trending as community members discuss its potential as a leading DEX and L1 ecosystem, highlighting its strong performance and unique features. Some believe it's undervalued and are urging others to add it to their watchlists, while speculation around potential listings and partnerships adds to the excitement. Bullish sentiment is fueled by discussions around staking rewards and growing transaction volume on the Hyperliquid platform.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending amid discussions around an FDA safety notice impacting specific lots of immune globulin products, including some of ADMA's ASCENIV and BIVIGAM. While some investors express concern over potential revenue impact and recent executive stock sales, others view this as a manageable operational risk inherent to the plasma-based therapy sector, particularly given the company's strong financials and growth prospects; the community also anticipates upcoming earnings and potential buyback activity as possible catalysts.

Brera Holdings Plc engages in the business of football division progression, global football player transfer service, sponsorship services, football school services, and consulting services on football projects. The company was founded on June 30, 2022 and is headquartered in Dublin, Ireland.

Brera Holdings PLC - Ordinary Shares - Class B

SLMT is trending due to its association with Solana and recent business updates, including plans for validator operations in the UAE and M&A strategy. The community is discussing the stock's low float, potential short squeeze, and Cathie Wood's ARK Invest's significant investment, with some anticipating a substantial price increase. Its rebranding as Solmate Infrastructure, focusing on Solana-based crypto treasury, and infrastructure business, is a hot topic.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster ($OUST) is trending as discussions revolve around its potential in the growing robotics and autonomy sectors, further supported by news of strategic partnerships and high institutional ownership. Community members are actively analyzing its technical setup and debating its valuation relative to peers, while keeping an eye on upcoming earnings and product roadmap updates. The company's diversified client base, innovative technology, and recurring revenue potential are seen as key drivers for future growth.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL (GRAL) is trending as investors discuss its potential for early cancer detection following promising data and a recent investment from Samsung, with community members highlighting its long-term growth prospects and potential for Medicare coverage. Some are focused on LEAPS option strategies, while others debate its valuation and competitive landscape. The community is also closely watching for FDA approval and broader adoption of its Galleri test.

Hyperion DeFi, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in Laguna Hills, CA.

Hyperion DeFi Inc.

HYPD is trending as investors discuss its relationship with the HYPE token and its potential to benefit from the Kinetiq iHYPE staking strategy. Community members are weighing the impact of institutional investments, potential short squeezes, and the company's overall financial health. Some express concerns about management and dilution, while others remain bullish on the company's crypto-focused pivot and potential for future growth.

VisionWave Holdings, Inc. engages in the forefront of revolutionizing defense capabilities by integrating advanced artificial intelligence (AI) and autonomous solutions across air, ground, and sea domains. The company was founded on September 3, 2024 and is headquartered in Wilmington, DE.

VisionWave Holdings Inc.

VisionWave Holdings, Inc.

VisionWave Holdings is trending due to its advancements in AI-driven defense technologies and recent news, including a joint venture and progress in Indian defense modernization. Community discussions revolve around the company's potential for growth in the defense sector, particularly its low float and potential for a short squeeze. The broader context includes mentions of AI, drone technology, and defense contracts, positioning VWAV as a compelling player in these sectors.

American Express Co. engages in the provision of card-issuing, merchant-acquiring, and card network businesses. Its products and services include credit cards, business credit cards, corporate programs, gift cards, savings accounts and CDs, and the American Express App. It operates through the following segments: the United States Consumer Services (USCS), Commercial Services (CS), International Card Services (ICS), Global Merchant and Network Services (GMNS), and Corporate and Other. The USCS segment includes proprietary consumer cards and provides services to United States consumers. The CS segment offers corporate and small business cards and provides services to United States businesses. The ICS segment provides consumers, small businesses, and corporate cards outside the United States. The GMNS segment is involved in operating a global payments network that processes and settles card transactions, acquires merchants, and provides multi-channel marketing programs and capabilities, services and data analytics. The Corporate and Other segment covers corporate functions and certain other businesses and operations. It also operates through the following geographical segments: United States, EMEA, APAC, LACC, and Other. The EMEA segment represents Europe, the Middle East, and Africa. The APAC segment refers to Asia Pacific, Australia, and New Zealand. The LACC segment focuses on Latin America, Canada, and the Caribbean. The Other segment includes net costs which are not directly allocated to specific geographic regions. The company was founded by Henry Wells, William G. Fargo, and John Warren Butterfield on March 28, 1850 and is headquartered in New York, NY.

American Express Co.

American Express is trending amid discussions around technical analysis, options activity, and upcoming earnings. Community members are weighing bullish and bearish perspectives, with some anticipating a breakout while others foresee a potential pullback. Recent analyst ratings and price target adjustments are also contributing to the increased attention on AXP.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon

Yunqi Capital Limited (together with its affiliates and the funds it advises, Yunqi Capital), an investment management firm and 5.1% shareholder of STAAR Surgical Company (STAAR or the Company...

Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction

Broadwood Partners, L.P. and its affiliates (Broadwood or we), which owns 27.5% of the outstanding common stock of STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA), today issued the...

Shares of STAAR Surgical Company (STAA) jumped 5% on Thursday afternoon after the firm announced that it had adjourned its special meeting of stockholders scheduled in connection with its merger agreement with Alcon (ALC).The meeting was originally scheduled for October 23 and has now been adjourned until 8:30 a.m. Pacific Time on November 6, 2025. The decision to postpone the meeting was made with Alcon, STAAR <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20251023361445/en/Alcon-and-STAAR-Surgical-Announce-Adjournment-of-STAAR-Special-Meeting-of-Stockholders">said.</a><h2 class="st-heading-2">Alcon-STAAR Deal</h2>STAAR is a manufacturer of phakic intraocular lenses, a vision correction solution that reduces or eliminates the need for glasses or contact lenses.Alcon, an eye care company, said in early August that it has entered into a definitive merger agreement with STAAR under which Alcon will purchase all outstanding shares of STAAR common stock for $28 per share in cash.The transaction was expected to close in about six to 12 months and represents a total equity value of approximately $1.5 billion, it added.<h2 class="st-heading-2">Shareholders Oppose Transaction</h2>The meeting adjournment follows resistance from several long-term shareholders to the proposed deal. Defender Capital <a href="https://stocktwits.com/news-articles/markets/equity/staar-surgical-long-term-shareholder-says-proposed-deal-with-alcon-undervalues-company/ch6P0tZR3hj">said</a> earlier this month that the proposed sales of STAAR to Alcon for $28 per share “significantly undervalues the company.” Defender Capital further added that it sees no compelling reason to sell STAAR at this time, with recent optimistic projections and outlook.Defender Capital is not the only one to oppose the proposed acquisition. Hong Kong-headquartered investment management firm Yunqi Capital, which holds a 5.1% stake in STAAR, <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20251020851506/en/Yunqi-Capital-Issues-Letter-to-STAAR-Surgicals-Board-Calling-for-Timely-Convening-of-the-Special-Meeting-to-Vote-on-the-Alcon-Transaction">said</a> earlier this week that it has voted its shares against the proposed deal.“While a 59% premium may appear compelling when viewed in isolation, shareholders understand that this figure is being presented without the fuller context of the company’s long-term trajectory – context the company itself has emphasized in past earnings materials,” Yunqi said.Broadwood Partners, L.P., and its affiliates, STAAR’s largest shareholder owning 27.5% of the company’s outstanding common shares, on Wednesday <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20251022937035/en/Broadwood-Partners-Intends-to-Call-Special-Meeting-to-Remove-Several-STAAR-Surgical-Directors">said</a> it intends to call a special meeting of STAAR shareholders to remove certain directors in light of its opposition to the proposed acquisition.“We anticipate that a refreshed Board would consider, among other matters, how to run a full, fair, independent, and open strategic alternatives process to maximize value that is untainted by the process issues and conflicts of interest that afflicted this proposed transaction with Alcon,” Broadwood President Neal C. Bradsher said, while also urging fellow shareholders to vote against the deal with Alcon.STAAR, however, has stated that it has not received any proposal to acquire the company other than from Alcon and that Alcon’s offer represents compelling and immediate cash value.“STAAR is confident that the Alcon transaction maximizes value for STAAR stockholders, is the only merger transaction available to the company, and if it is not approved, the value of your shares is at risk of declining substantially,” the company said in a statement earlier this month.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/STAA">STAA stock</a> stayed within the ‘neutral’ territory over the past 24 hours, while message volume stayed at ‘low’ levels.<figure class="image"><img style="aspect-ratio:620/59;" src="data:image/png;base64,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" width="620" height="59" alt="STAA's Sentiment Meter and Message Volume as of 1:00 p.m. ET on Oct. 23, 2025 | Source: Stocktwits"><figcaption>STAA's Sentiment Meter and Message Volume as of 1:00 p.m. ET on Oct. 23, 2025 | Source: Stocktwits</figcaption></figure>STAA stock is up by 8% this year but has fallen 13% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/unitedhealth-optum-cfo-reportedly-exits-in-less-than-six-months-into-role/cLG4VcAR3rK">UnitedHealth’s Optum CFO Reportedly Exits In Less Than Six Months Into The Role</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

STAAR Surgical Stock Rises After Adjournment Of Stockholders’ Meeting To Discuss Proposed Merger With Alcon

The meeting was originally scheduled for October 23 and has now been adjourned until 8:30 a.m. Pacific Time on Nov. 6, 2025.

Equity

Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer Lens (ICL...

Here's Why Alcon (ALC) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Broadwood Partners Issues Letter to STAAR Surgicals Board Urging it to Allow Timely Shareholder Vote on Alcon Sale

Broadwood Partners, L.P. and its affiliates (collectively, Broadwood) today issued the following letter to the Board of Directors (the Board) of STAAR Surgical Company (STAAR or the Company) (NASDAQ...

Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote AGAINST Sale to Alcon

Broadwood Partners, L.P. and its affiliates (Broadwood or we) today announced that Institutional Shareholder Services Inc. (ISS), a leading independent proxy advisory firm, has recommended that the...

Broadwood Partners Comments on STAAR Surgicals Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon

Broadwood Partners, L.P. and its affiliates (Broadwood or we) today commented on the recent Current Report on Form 8-K filed by STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA) with the...

Broadwood Partners Issues Letter to STAAR Surgicals Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale

Don't Overlook These 2 Highly Ranked Medical Stocks: COLL, MASI

Two medical sector stocks are standing out among the recent additions to the Zacks Rank #1 (Strong Buy) list in Collegium Pharmaceutical (COLL) and Masimo Corporation (MASI). 

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner in 1945 and is headquartered in Geneva, Switzerland.

Alcon Inc. - Registered Shares

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$0.76	--	--	N/A
Q2 '25	$0.72	$0.76	6.22%	BEAT
Q1 '25	$0.75	$0.73	-3.15%	MISSED
Q4 '24	$0.71	$0.72	1.85%	BEAT
Q3 '24	$0.74	$0.81	9.19%	BEAT

ALC
Alcon Inc. - Registered Shares

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest ALC News

ALCAlcon Inc. - Registered Shares